Top compounds associated with response to PSMD6


Feature Type Standardized
Nominal ANOVA
mRNA fulvestrant CTRPv2 pan-cancer AAC 0.32 3e-05
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0003
mRNA NVP-BEZ235 GDSC1000 pan-cancer AAC 0.13 0.0006
mRNA Panobinostat CTRPv2 pan-cancer AAC -0.11 0.0008
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.16 0.0009
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.0009
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.003
mRNA Doxorubicin gCSI pan-cancer AAC 0.15 0.003
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.1 0.004
mRNA neratinib CTRPv2 pan-cancer AAC -0.1 0.005
Download CSV